WebPhesgo® Type of Product: Combination of two humanized (IgG1, kappa) monoclonal antibodies. Active Pharmaceutical Ingredient(s): Pertuzumab and Trastuzumab. ATC … Web25. jan 2024 · Phesgo 600 mg/ 600 mg and 1200 mg/ 600 mg solution for injection SPC Medicines.ie. Search Medicine Database. Home. Medicines. Phesgo 600 mg/ 600 mg and …
DESCRIPTION THERAPEUTIC / PHARMACOLOGIC CLASS OF …
WebClick to view Phesgo detailed prescribing information Dosage/Direction for Use SC EBC & MBC Loading dose: Pertuzumab 1,200 mg/trastuzumab 600 mg for approx 8 min. Maintenance dose: Pertuzumab 600 mg/trastuzumab 600 mg for approx 5 min every 3 wk. Patient receiving taxane Administer prior to taxane. Recommended initial dose of … WebPhesgo: 1200 mg / 600 mg/ 15 mL: Solution For Injection (SC) F. Hoffmann-La Roche, Ltd. Switzerland: Monitored Release: 29 July 2024: 29 July 2027: View: BR-1408: Pertuzumab + Trastuzumab: ... 100 mg/mL: Solution for Injection (S.C.) Vetter Pharma-Fertigung GmbH & Co. KG: Germany: Monitored Release: 13 September 2024: 13 September 2027: View: fmcsa 395.8(j)(2)
Fiche info - PHESGO 1200 mg/600 mg, solution injectable - Base …
Web21. dec 2024 · PHESGO 1200 mg/600 mg, solution injectable : Date de l'autorisation : 21/12/2024. Cliquez sur un pictogramme pour aller directement à la rubrique le concernant. Pour plus d'information sur les pictogrammes, consultez l'aide. : Ce médicament fait l'objet d'une surveillance renforcée. Web16. mar 2024 · Phesgo 1200 mg/600 mg solution for injection - Patient Information Leaflet (PIL) - (emc) Phesgo 1200 mg/600 mg solution for injection Active Ingredient: … WebPhesgo® Type of Product: Combination of two humanized (IgG1, kappa) monoclonal antibodies. Active Pharmaceutical Ingredient(s): Pertuzumab and Trastuzumab. ATC code: L01XY02. Dosage Form: Solution for injection. Dosage Strength: - 600 mg / 600 mg – 10 ml vial. - 1200 mg / 600 mg – 15 ml vial. Pack Size: 1. Shelf life: 18 Months. fmcsa 396.11.a.1